RACCE Study: Impact of an enhanced recovery after surgery program (ERAS) in the management of endometrial cancer: A single-center retrospective study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101701588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-7847 (Electronic) Linking ISSN: 24687847 NLM ISO Abbreviation: J Gynecol Obstet Hum Reprod Subsets: MEDLINE
    • Publication Information:
      Original Publication: Paris : Elsevier Masson SAS, [2017]-
    • Subject Terms:
      Enhanced Recovery After Surgery* ; Endometrial Neoplasms*; Humans ; Female ; Retrospective Studies ; Postoperative Complications ; Hospitals, University
    • Abstract:
      Objective: This study evaluates the implementation of an ERAS program in the gynecological surgery department of Caen University Hospital and its impact on the management of endometrial cancer. The objective was to show its impact on the length of hospitalization of patients before and after its implementation.
      Patients and Method: We conducted a retrospective study including all women treated surgically for endometrial cancer at Caen University Hospital between January 1, 2015 and December 31, 2021. The ERAS program started in September 2017. We compared the pre-, intra- and postoperative characteristics of two groups: the first one concerning the period before the implementation of ERAS called « prior ERAS group » and the second one after implementation called « post ERAS group ».
      Results: A total of 198 patients were included in our study. 139 patients were included after ERAS implementation. Our study shows that there is a significant reduction in median length of stay between the post ERAS and prior ERAS groups respectively 3 and 4 days (p = 0.004). There was also a reduction of time to resume ambulation (p < 0.001) and re-feeding (p < 0.001) for the post ERAS group compared to the prior ERAS group. Complication rates (p = 0.87) and readmission rates (p = 0.28) were not significant. Overall survival was not significant (p = 0.28).
      Conclusion: ERAS is a safe and effective method in the overall management of patients allowing an improvement in the quality of patient care and accelerating recovery to a previous physiological state. Finally, this results in a reduction in the patient's length of stay, without impacting morbidity and readmission rate.
      (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
    • Contributed Indexing:
      Keywords: Ambulation; ERAS; Endometrial cancer; Enhanced recovery after surgery; Laparoscopy; Postoperative complications; Re-feeding
    • Publication Date:
      Date Created: 20230126 Date Completed: 20230227 Latest Revision: 20230227
    • Publication Date:
      20231215
    • Accession Number:
      10.1016/j.jogoh.2023.102543
    • Accession Number:
      36702400